About this trial
This study was a prospective multicenter cohort of severe pneumonia. And by collecting clinical samples to clarify the correlation between lung microbiome, intestinal microbiome, host susceptibility, and prognosis of severe pneumonia patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Expected length of stay in ICU is less than 1 day
Pregnant
Trial population
Overall, the investigators will include all severe pneumonia patients transferred to the ICU, including community acquired pneumonia, hospital acquired pneumonia, and ventilator-associated pneumonia.
Trial design
Cohort
Prospective
Treatments tested in this trial
Metagenomics
Diagnostic testClinical metagenomics is used to evaluate pathogens
Treatment groups
Trial outcomes
Primary outcomes
The correlation between lung microbiome and disease prognosis
1\. Identification of microbial gene profiles; 2. Analysis of host health dynamics and trends; 3. Identification of host gene mutations; 4. Preliminary model construction; 5. Model optimization and evaluation.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.